Cencast

Inpharmation, widely known for its flagship Cencast platform, is a leading provider of demand forecasting software and strategic consultancy services for the pharmaceutical and biotechnology industries. The company specializes in evidence-based forecasting, utilizing advanced methodologies to predict market uptake and commercial potential for new drug candidates. Its Cencast software is considered an industry standard, used by a significant majority of the world's top 50 pharmaceutical companies to support investment decisions and portfolio management. In 2022, Inpharmation was acquired by Lumanity, integrating its specialized forecasting capabilities into a broader suite of commercialization and market access solutions.